Cargando…
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
COVID-19 has spread worldwide since 2019 and is now a severe threat to public health. We previously identified the causative agent as a novel SARS-related coronavirus (SARS-CoV-2) that uses human angiotensin-converting enzyme 2 (hACE2) as the entry receptor. Here, we successfully developed a SARS-Co...
Autores principales: | Jiang, Ren-Di, Liu, Mei-Qin, Chen, Ying, Shan, Chao, Zhou, Yi-Wu, Shen, Xu-Rui, Li, Qian, Zhang, Lei, Zhu, Yan, Si, Hao-Rui, Wang, Qi, Min, Juan, Wang, Xi, Zhang, Wei, Li, Bei, Zhang, Hua-Jun, Baric, Ralph S., Zhou, Peng, Yang, Xing-Lou, Shi, Zheng-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241398/ https://www.ncbi.nlm.nih.gov/pubmed/32516571 http://dx.doi.org/10.1016/j.cell.2020.05.027 |
Ejemplares similares
-
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013) -
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
por: Jiang, Fan, et al.
Publicado: (2014) -
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
por: Lutz, Cathleen, et al.
Publicado: (2020) -
Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats
por: Li, Yong-Hong, et al.
Publicado: (2013)